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Diploidy, though essential for normal development, is a foil to geneticists. Two recent studies (Elling et al.,
2011, this issue of Cell Stem Cell; Leeb and Wutz 2011, Nature), report the isolation of haploid pluripotent
mouse ESCs, thus enabling efficient functional screening for genes involved in diverse cellular and develop-
mental processes.As we strive to understand the function of
all genes in the mammalian genome, a
barrier to rapid progress is the fact that
mammals are diploid. Therefore, reces-
sive mutations usually must be rendered
homozygous to uncover the function of
the cognate genes. This major incon-
venience has caused this author, and
many of his colleagues working on mice
or humans, to develop a severe case of
‘‘yeast envy.’’ That fungal spores can
grow in the haploid state, coupled with
the modern availability of a comprehen-
sive gene deletion collection for Sac-
charomyces cerevisiae, enables facile
forward and reverse genetic screens for
recessive mutations of limitless pheno-
types on a genome-wide scale.
Despite the availability of gene target-
ing technology in embryonic stem cells
(ESCs), and the progress of the inter-
national Knockout Mouse Consortium
(http://www.knockoutmouse.org) that is
systematically generating knockouts in
all mouse genes (analogous to the yeast
deletion collection), reverse genetic
screening of genes for recessive pheno-
types remains difficult. Either the ESCs
must be converted into mice for inter-
crossing and generation of homozygous
animals and cells, or the heterozygous
ESCs must be subjected to a second
round of targeted mutagenesis or selec-
tion for loss of the remaining WT allele
by spontaneous or induced mitotic re-
combination (Koike et al., 2002; Morten-
sen et al., 1992). All of these methods
are relatively inefficient and nontrivial.
The advent of siRNA has largely displaced
the need for such strategies in cell culture
paradigms, and is effective for knock-
down, but not always total elimination, of
target gene expression. A drawback is488 Cell Stem Cell 9, December 2, 2011 ª20the issue of effective delivery in more
complicated scenarios, such as those
involving long-term culture or whole ani-
mals, and siRNA transfection is simply
not readily scalable for all 23,000 genes
en masse.
Forward genetic screens in mammalian
cells via random mutagenesis present a
far more difficult problem, because they
demand biallelic inactivation without
prior knowledge of the genes that may
cause a recessive phenotype. Some elab-
orate strategies have been employed in
ESCs, involving, for example, retrovirally
mutagenized ESCs subsequently stimu-
lated to undergo random loss of het-
erozygosity (LOH) (Horie et al., 2011).
The generation and distribution of viral
vector-based shRNA libraries has been
revolutionary for forward genetic screens
(for example, see Westbrook et al., 2005),
but suffers from oft-ineffective knock-
downs (a problem being addressed by
evolving generations of shRNAs [Fellmann
et al., 2011] and vectors suitable for mice
[Premsrirut et al., 2011]) and cost of com-
prehensive libraries.
The recent papers in Nature (Leeb and
Wutz, 2011) and this issue of Cell Stem
Cell (Elling et al., 2011) reporting the gen-
eration of haploid ESCs provide a poten-
tially very important advance for forward
genetics in mice and humans. Before dis-
cussing this obvious point, let’s consider
how the authors accomplished this feat.
We have known for some time how to
make parthenogenetic embryos from un-
fertilized oocytes. Normally, fertilization
triggers calcium oscillations in the egg
and subsequent zygotic development.
This process can be mimicked by treating
unfertilized oocytes with agents such
as strontium chloride or ethanol (Malcuit11 Elsevier Inc.et al., 2006). Elling et al. (2011) transferred
activated oocytes into pseudopregnant
females, withdrew them at the blastocyst
stage (embryonic day 3.5), and plated
them to derive ESCs under entirely stan-
dard conditions. Upon establishment of
lines, the critical trick used by both stud-
ies was to FACS sort cells with haploid
DNA content. Elling et al. (2011) derived
two sublines, each derived from an orig-
inal blastocyst. In both studies, F1 hybrid
oocytes were used; it is not clear whether
this is critical for success or efficiency of
haploid ESC derivation.
Both studies performed a similar set of
experiments to assess the resemblance
of haploid to normal ESCs. The haploid
lines expressed expected pluripotency
markers (Oct4, Klf4, Nanog, et cetera),
had gene expression profiles very similar
to those of diploid lines (with the excep-
tion of X- and Y-linked genes), and formed
embryoid bodies and teratomas with cell
types representing all three germ layers.
Although DNA sequencing analyses pro-
vided some evidence for copy number
alterations in haploid ESC genomes ex-
amined by Elling et al., array comparative
genomic hybridization (aCGH; a lower re-
solution method) revealed no major geno-
mic alterations in the study by Leeb and
Wutz (2011). One important caveat is
that the haploid ESCs, even after sub-
cloning, are not stably haploid; for one
such subclone, Elling et al. estimated
that 2%–3% of cells become diploid
every day in culture. Finally, haploid ESCs
(Leeb and Wutz, 2011), or diploid ESCs
derived from haploid ESC lines (Elling
et al., 2011), were able to contribute to
tissues of chimeric embryos and adult
animals. In the former case, most of the
progenitors of GFP-marked haploid ESCs
Figure 1. Derivation of Haploid Embryonic Stem Cells and Utilization for Mutation Screens
(A) Procedure of haploid ESC derivation. There are only two notable differences compared with standard
ESC generation. One difference is that chemicals (e.g., SrCl2) are used to stimulate isolated oocytes
in vitro to complete meiosis and develop into blastocysts, rather than male mice to activate (fertilize)
oocytes in vivo before we allow them to develop into blastocysts. The other difference is that FACs is
used to isolate pure sublines of haploid ESCs.
(B) Mutagenesis of haploid ESCs. The ESCs can be mutagenized with retrovirally borne or plasmid-borne
random disruption vectors (such as the gene traps used in the published studies discussed herein), or
alternatively, other agents such as chemical mutagens. The mutagenized cells can be subjected to direct
phenotypic selection, as done in these reports. However, it is also conceivable to differentiate the muta-
genized ESCs intomultiple cells types (shown here are neurons andmuscle cells), then apply a selection or
screen. Another version of a screen would be to test the ability of individual clones to differentiate into
various cell types. Inability to do so would suggest that such lines are disrupted for a key gene needed
for that cell lineage.
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tion in the differentiated tissues. In sum,
the haploid ESCs retain characteristic
ESC pluripotential properties, though the
haploid state is simply not compatible
with most differentiated cell types or tis-
sues. This does not diminish the potential
utility of these reagents, as explained
below.
Both groups were clearly motivated
by the potential power of haploid ESCs
for forward genetics. Using retroviral in-
sertional vectors, haploid ESCs were
screened in one case for ricin resistance,
and in the other case, for DNA repair defi-
ciency. Because it is simple to generate
several millions of ESCs containing in-
dependent integrations of a virally intro-
duced gene trap vector, and because
the insertion sites of the vectors are deter-
mined easily by PCR-based methods,
one can devise screens for mutants caus-
ing diverse phenotypes and determine the
underlying gene defect. Elling et al. (2011)
generated millions of transformants in
a single experiment. They used a clever
vector in which those genes containing
insertions in the one orientation (anti-sense) are conditional, but Cre expression
flips a splice acceptor into the sense
orientation to ‘‘activate’’ trapping activity
that causes transcript truncation. As proof
of principle, the authors identified lines
with insertions in particular genes in-
cluding Drosha that show expected phe-
notypes (i.e., defect in miRNA processing)
upon Cre activation of the allele (Elling
et al., 2011). They also conducted a for-
ward genetic screen of their library for
mutations in genes causing resistance to
the poisonous bioweapon ricin, finding
not only genes expected to mediate ricin
toxicity, but also an additional novel and
unexpected target (Gpr107).
While the ricin resistance phenotype is
a good example of screening for pheno-
types that are relatively general for mam-
malian cells, obviously it is possible to
conduct screens for mutations specific
to ESC functions, or more excitingly, for
cell types into which ESCs can be differ-
entiated in vitro (Figure 1). It is important
to note that although the haploid ESCs
convert to diploids fairly frequently, as
long as the library is made from freshly
sorted haploid cells, as in Elling et al.Cell Stem Cell 9,(2011), diploidization is not a problem
because the insertions will be present in
both ‘‘alleles.’’
An interesting remaining question re-
lates to imprinting status of haploid ESCs,
and how it might change upon sponta-
neous diploidization. Although gene ex-
pression profiling was performed in both
studies, it was not mentioned whether
genes that are normally imprinted (inac-
tive) maternally are expressed, given that
normal diploid ESCs exhibit DNAmethyla-
tion marks reflective of parent-of-origin
imprinting, though these marks are un-
stable over time (Humpherys et al., 2001).
These issues will likely determine whether
it is possible for haploid ESCs, after dip-
loidization, to colonize the germline. If so,
diverse alleles selected from forward gen-
etic mutation screens can be converted
into animal models. That would be a truly
powerful outcome.
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